ストックスクリーナーアプリを入手
2.52
1.20%
0.03
アフターアワーズ：
2.56
0.04
+1.59%
前日終値:
$2.49
開ける：
$2.45
24時間の取引高:
1.23M
Relative Volume:
1.18
時価総額：
$273.00M
収益：
$27.08M
当期純損益:
$-37.00M
株価収益率:
-4.8462
EPS:
-0.52
ネットキャッシュフロー:
$-18.46M
1週間 パフォーマンス:
+17.21%
1か月 パフォーマンス:
+32.63%
6か月 パフォーマンス:
+82.61%
1年 パフォーマンス:
+39.23%
1日の値動き範囲:
$2.44
$2.62
1週間の範囲:
$2.15
$2.62
52週間の値動き範囲:
$1.05
$5.17
Aclaris Therapeutics Inc Stock (ACRS) Company Profile
ACRS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ACRS
Aclaris Therapeutics Inc
|
2.52 | 269.75M | 27.08M | -37.00M | -18.46M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Piper Sandler | Overweight |
| 2025-05-28 | 開始されました | Wedbush | Outperform |
| 2025-03-18 | 再開されました | Cantor Fitzgerald | Overweight |
| 2024-12-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2024-11-20 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2024-11-19 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-11-19 | アップグレード | Jefferies | Hold → Buy |
| 2024-11-19 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-11-18 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-01-22 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-11-13 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-10-03 | 開始されました | Evercore ISI | Outperform |
| 2022-12-14 | 開始されました | Stifel | Buy |
| 2022-12-01 | 開始されました | Goldman | Buy |
| 2022-10-06 | 開始されました | BTIG Research | Buy |
| 2021-07-23 | 再開されました | Jefferies | Buy |
| 2021-06-15 | 開始されました | Piper Sandler | Overweight |
| 2021-04-21 | 開始されました | H.C. Wainwright | Buy |
| 2019-10-22 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-09-06 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2019-06-27 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2019-05-06 | 開始されました | SVB Leerink | Outperform |
| 2018-03-28 | 再開されました | Leerink Partners | Outperform |
| 2018-02-09 | 開始されました | Guggenheim | Buy |
| 2017-06-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2016-11-29 | 開始されました | Leerink Partners | Outperform |
| 2016-09-30 | 開始されました | JMP Securities | Mkt Outperform |
| 2016-06-10 | 開始されました | Guggenheim | Buy |
| 2015-11-02 | 開始されました | Citigroup | Buy |
| 2015-11-02 | 開始されました | Jefferies | Buy |
すべてを表示
Aclaris Therapeutics Inc (ACRS) 最新ニュース
How Aclaris Therapeutics Inc. (8AT) stock performs during market turbulenceJuly 2025 News Drivers & Fast Entry Momentum Alerts - newser.com
Why Aclaris Therapeutics Inc. (8AT) stock gets analyst attentionQuarterly Investment Review & Capital Protection Trade Alerts - newser.com
Aclaris Therapeutics (NASDAQ:ACRS) adds US$40m to market cap in the past 7 days, though investors from three years ago are still down 83% - Yahoo Finance
How Aclaris Therapeutics Inc. stock trades before earningsWeekly Profit Report & Daily Stock Momentum Reports - newser.com
Statistical indicators supporting Aclaris Therapeutics Inc.’s strength2025 Key Highlights & Free Real-Time Volume Trigger Notifications - newser.com
Is Aclaris Therapeutics Inc. stock a contrarian buy2025 Valuation Update & Fast Exit Strategy with Risk Control - newser.com
How to use a screener to detect Aclaris Therapeutics Inc. breakoutsJuly 2025 Big Picture & Expert Curated Trade Setup Alerts - newser.com
Can you recover from losses in Aclaris Therapeutics Inc.Market Activity Report & Free Fast Gain Swing Trade Alerts - newser.com
Will Aclaris Therapeutics Inc. benefit from macro trendsJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com
Key resistance and support levels for Aclaris Therapeutics Inc.IPO Watch & Technical Entry and Exit Tips - newser.com
Is Aclaris Therapeutics Inc. (8AT) stock a momentum leaderAnalyst Downgrade & Low Risk Profit Maximizing Plans - newser.com
Why Aclaris Therapeutics Inc. stock attracts global investorsWeekly Investment Summary & Fast Entry High Yield Stock Tips - newser.com
Risk adjusted return profile for Aclaris Therapeutics Inc. analyzedJuly 2025 Setups & Weekly Breakout Stock Alerts - newser.com
Applying chart zones and confluence areas to Aclaris Therapeutics Inc.2025 Top Gainers & Daily Price Action Insights - newser.com
What drives Aclaris Therapeutics Inc stock priceContrarian Investment Ideas & Investment Recommendations You Can Trust - earlytimes.in
Will Aclaris Therapeutics Inc. stock outperform international peersNew Guidance & Verified Trade Idea Suggestions - newser.com
Aclaris Therapeutics Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Will Aclaris Therapeutics Inc. (8AT) stock benefit from mergersQuarterly Performance Summary & Expert Curated Trade Ideas - newser.com
Aclaris Therapeutics, Inc.'s (NASDAQ:ACRS) Shares Climb 31% But Its Business Is Yet to Catch Up - 富途牛牛
Revenues Not Telling The Story For Aclaris Therapeutics, Inc. (NASDAQ:ACRS) After Shares Rise 31% - simplywall.st
Will Aclaris Therapeutics Inc. (8AT) stock hit Wall Street targetsOptions Play & Daily Growth Stock Tips - newser.com
Aclaris Therapeutics’ ATI-045 Study: A Potential Game-Changer for Atopic Dermatitis - TipRanks
Will Aclaris Therapeutics Inc. stock outperform Dow Jones indexMarket Risk Analysis & Low Risk Investment Opportunities - newser.com
Using Python tools to backtest Aclaris Therapeutics Inc. strategiesMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
Acadian Increases Stake in Aclaris Therapeutics, Inc. (ACRS) as Phase 2a Data Gains Spotlight - MSN
Aclaris Therapeutics to Participate in Three November Healthcare Conferences - Investing News Network
Aclaris Therapeutics Inc (ACRS) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):